ALXN1210

ALXN1210 · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ALXN1210, covering 2018-01-30 to 2024-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants [Phase 1]